Avid Bioservices (CDMO) News Today $12.50 +0.02 (+0.12%) Closing price 02/5/2025Extended Trading$12.50 0.00 (0.00%) As of 02/5/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDMO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Comparing Avid Bioservices (NASDAQ:CDMO) and Eliem Therapeutics (NASDAQ:ELYM)June 4, 2025 | americanbankingnews.comAvid Bioservices launches new company website designFebruary 10, 2025 | markets.businessinsider.comAvid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor ExperienceFebruary 10, 2025 | globenewswire.comAvid Bioservices (NASDAQ:CDMO) Reaches New 12-Month High - Still a Buy?Avid Bioservices (NASDAQ:CDMO) Hits New 12-Month High - Still a Buy?February 6, 2025 | marketbeat.comJennison Associates LLC Makes New $13.80 Million Investment in Avid Bioservices, Inc. (NASDAQ:CDMO)Jennison Associates LLC purchased a new stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,117,104 shares of the biopharmaceutical company's stock, valued at approximately $13,796,February 6, 2025 | marketbeat.comGHO Capital, Ampersand Capital announce closing of Avid Bioservices acquisitionFebruary 6, 2025 | markets.businessinsider.comAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed MergerFebruary 5, 2025 | globenewswire.comAvid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital PartnersFebruary 5, 2025 | globenewswire.comAvid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital PartnersFebruary 5, 2025 | globenewswire.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by Sargent Investment Group LLCSargent Investment Group LLC cut its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 32.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 377,694 shares of the biopharmaceutical company'sFebruary 5, 2025 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - Here's What HappenedAvid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - Should You Buy?February 4, 2025 | marketbeat.comTokio Marine Asset Management Co. Ltd. Takes $7.32 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO)Tokio Marine Asset Management Co. Ltd. bought a new position in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 592,700 shares of the biopharmaceutical coFebruary 2, 2025 | marketbeat.comDouble Digit IRR Likely With Avid BioservicesFebruary 1, 2025 | seekingalpha.comCDMO stock soars to 52-week high, hits $12.48 amid robust growthJanuary 31, 2025 | msn.comAvid Bioservices (NASDAQ:CDMO) Sets New 1-Year High - Should You Buy?Avid Bioservices (NASDAQ:CDMO) Sets New 1-Year High - What's Next?January 31, 2025 | marketbeat.comAvid Stockholders Approve Transaction with GHO and AmpersandJanuary 30, 2025 | globenewswire.comMcGuire Investment Group LLC Has $145,000 Position in Avid Bioservices, Inc. (NASDAQ:CDMO)McGuire Investment Group LLC lessened its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 64.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 11,728 shares of the biopharmaceutical company's stockJanuary 25, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 80,308 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)JPMorgan Chase & Co. increased its position in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 283.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 108,684 shares of the biopharmaceutical company's stock after purchasing an additJanuary 25, 2025 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Share Price Passes Above 200-Day Moving Average - Here's WhyAvid Bioservices (NASDAQ:CDMO) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?January 23, 2025 | marketbeat.comAvid Bioservices says ISS, Glass Lewis recommend vote ‘FOR’ transactionJanuary 22, 2025 | markets.businessinsider.comAvid Bioservices (CDMO) Started a Sale ProcessJanuary 22, 2025 | msn.comAvid Reminds Stockholders to Vote Today FOR the Transaction with GHO and AmpersandJanuary 22, 2025 | globenewswire.comAvid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and AmpersandJanuary 21, 2025 | markets.businessinsider.comAvid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - Should You Buy?Avid Bioservices (NASDAQ:CDMO) Sees Large Volume Increase - Time to Buy?January 15, 2025 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Insider Richard A. Richieri Sells 2,283 Shares of StockJanuary 14, 2025 | insidertrades.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,283 Shares of StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) insider Richard A. Richieri sold 2,283 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $12.37, for a total transaction of $28,240.71. Following the completion of the sale, the insider now directly owns 49,535 shares of the company's stock, valued at approximately $612,747.95. This trade represents a 4.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.January 13, 2025 | marketbeat.comBarclays PLC Acquires 66,653 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Barclays PLC grew its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 98.1% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 134,598 shares of the biopharmaceutical company's stock after purchasinJanuary 13, 2025 | marketbeat.comAvid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and AmpersandJanuary 8, 2025 | globenewswire.comAvid Bioservices (NASDAQ:CDMO) Stock Crosses Above 200 Day Moving Average - Should You Sell?Avid Bioservices (NASDAQ:CDMO) Shares Pass Above 200-Day Moving Average - Here's What HappenedJanuary 8, 2025 | marketbeat.comAVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMOJanuary 6, 2025 | businesswire.comAvid Bioservices, Inc. (NASDAQ:CDMO) Short Interest UpdateAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 10,710,000 shares, a decline of 8.0% from the November 30th total of 11,640,000 shares. Based on an average trading volume of 1,830,000 shares, the short-interest ratio is currently 5.9 days.January 1, 2025 | marketbeat.comAvid Bioservices announces expiration of HSR waiting period for acquisitionDecember 31, 2024 | markets.businessinsider.comAvid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and AmpersandDecember 30, 2024 | globenewswire.comBarclays PLC Buys 66,653 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Barclays PLC boosted its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 98.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 134,598 shares of the biopharmaceutical company's stock after puDecember 29, 2024 | marketbeat.comCDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to ShareholdersDecember 28, 2024 | businesswire.comAvid Bioservices, Inc. (NASDAQ:CDMO) Insider Richard A. Richieri Sells 3,843 SharesDecember 28, 2024 | insidertrades.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 3,843 Shares of StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) insider Richard A. Richieri sold 3,843 shares of the stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $12.22, for a total transaction of $46,961.46. Following the completion of the sale, the insider now owns 44,556 shares of the company's stock, valued at approximately $544,474.32. This represents a 7.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.December 27, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) CFO Daniel R. Hart Sells 22,813 SharesAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) CFO Daniel R. Hart sold 22,813 shares of the business's stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $12.22, for a total transaction of $278,774.86. Following the sale, the chief financial officer now directly owns 110,980 shares in the company, valued at approximately $1,356,175.60. This represents a 17.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.December 27, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) CEO Nicholas Stewart Green Sells 145,911 SharesAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) CEO Nicholas Stewart Green sold 145,911 shares of Avid Bioservices stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $12.22, for a total transaction of $1,783,032.42. Following the completion of the sale, the chief executive officer now owns 157,620 shares of the company's stock, valued at $1,926,116.40. This represents a 48.07 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.December 27, 2024 | marketbeat.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) CEO Sells 75,000 Shares of StockDecember 27, 2024 | insidertrades.comAvid Bioservices, Inc. (NASDAQ:CDMO) CEO Sells $923,250.00 in StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) CEO Nicholas Stewart Green sold 75,000 shares of the firm's stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $12.31, for a total value of $923,250.00. Following the completion of the transaction, the chief executive officer now directly owns 151,653 shares in the company, valued at $1,866,848.43. The trade was a 33.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.December 26, 2024 | marketbeat.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) CEO Sells 100,000 Shares of StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) CEO Nicholas Stewart Green sold 100,000 shares of the business's stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $12.28, for a total transaction of $1,228,000.00. Following the sale, the chief executive officer now directly owns 51,653 shares of the company's stock, valued at $634,298.84. This represents a 65.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.December 26, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by State Street CorpState Street Corp decreased its position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 9.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,002,503 shares of the biopharmaceutical company's stock afDecember 21, 2024 | marketbeat.comAvid Bioservices Recommends Stockholders Vote FOR Value Maximizing TransactionDecember 18, 2024 | globenewswire.comFmr LLC Raises Stake in Avid Bioservices, Inc. (NASDAQ:CDMO)Fmr LLC increased its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 1,010.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,096 shares of the biopharmaceutical company's stock after pDecember 18, 2024 | marketbeat.comLord Abbett & CO. LLC Invests $6.19 Million in Avid Bioservices, Inc. (NASDAQ:CDMO)Lord Abbett & CO. LLC purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 544,300 shares of the biopharmaceutiDecember 17, 2024 | marketbeat.comCraig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)December 12, 2024 | markets.businessinsider.comAvid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024December 10, 2024 | globenewswire.comCraig-Hallum Issues a Hold Rating on Avid Bioservices (CDMO)December 7, 2024 | markets.businessinsider.comStephens Downgrades Avid Bioservices (NASDAQ:CDMO) to HoldStephens lowered Avid Bioservices from a "strong-buy" rating to a "hold" rating in a report on Wednesday.December 6, 2024 | marketbeat.com Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address CDMO Media Mentions By Week CDMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDMO News Sentiment▼0.670.68▲Average Medical News Sentiment CDMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDMO Articles This Week▼12▲CDMO Articles Average Week Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTGX News CPRX News CRNX News MTSR News VKTX News MOR News SRRK News KYMR News MLTX News IMVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDMO) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDMO Stock Free CDMO Stock Alerts